Monitoring and Management of Bacterial Resistance to Antimicrobial Agents. WHO Symposium. Geneva (CHE), 1994/11/29.
Infectious diseases continue to be major threats to human health around the world.
Within the past few years, several divergent groups of organisms have emerged as significant causes of morbidity and mortality.
Included among these are bacteria that are refractory to therapy because of the development of resistance to multiple antimicrobial agents.
Multidrug resistance in strains of Mycobacterium tuberculosis, Streptococcus pneumoniae, Shigella dysenteriae, Salmonella typhi, and Enterococcus faecium has been reported.
Surveillance of resistant microorganisms in the United States and abroad is fragmentary and targets relatively few organisms.
Surveillance is further hampered by the fact that detection of some novel resistance mechanisms is difficult by means of current laboratory methods.
Both clinicians and public health officials are likely to continue to face a variety of challenges regarding surveillance, treatment, prevention, and control of drug-resistant infections.
Mots-clés Pascal : Programme sanitaire, Surveillance sanitaire, Méthode, Dépistage, Bactérie, Virus, Antimicrobien, Résistance, Homme, Fungi, Thallophyta, Antibiotique
Mots-clés Pascal anglais : Sanitary program, Sanitary surveillance, Method, Medical screening, Bacteria, Virus, Antimicrobial agent, Resistance, Human, Fungi, Thallophyta, Antibiotic
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0156324
Code Inist : 002B05A01. Création : 21/05/1997.